Saturday 17 October 2026
Export ENVB’s income statement to Excel — free account
Enveric Biosciences, Inc.
ENVB Healthcare Biotechnology
In the quarter to June 2026, EPS grew 93.5% and free cash flow fell 29.3%, each against the same quarter a year earlier.
1.38
0.01
−0.72%
Follow ENVB
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
— | — | — | — |
+8 more quarters Free account |
EV/Sales |
— | — | — | — | |
EV/FCF |
— | — | — | — | |
Quick Ratio |
9.63 | 10.66 | 5.09 | 4.15 | |
Current Ratio |
10.21 | 11.67 | 5.38 | 4.60 | |
Net Debt/EBITDA |
2.77 | 3.08 | 2.17 | 2.05 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.81 | 1.38 | 0.44 | 0.61 | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 | |
Interest Coverage |
(10,091.33) | — | — | 6,246.33 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow Yield |
— | — | — | — | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.61) | (1.49) | (5.33) | (6.63) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(0.61) | (1.49) | (5.33) | (6.63) | |
Cash per Share |
2.08 | 3.25 | 13.98 | 12.00 | |
Shareholders Equity per Share |
2.03 | 3.35 | 12.48 | 11.04 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
2.03 | 3.35 | 12.48 | 11.04 | |
Free Cash Flow |
(2.44) | (2.26) | (1.78) | (2.07) | |
Working Capital |
7.93 | 4.91 | 4.02 | 3.26 | |
Net Current Asset Value |
7.93 | 4.91 | 4.02 | 3.26 | |
| Other line items | |||||
Average Payables |
0.86 | 0.47 | 0.55 | 0.63 | |
Average Assets |
6.25 | 5.31 | 4.09 | 4.58 | |
Average Common Equity |
5.13 | 4.49 | 2.89 | 3.70 |
Columns are period end dates